Is Heraclene (generic name) safe to use in patients with Chronic Kidney Disease (CKD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heraclene Safety in Chronic Kidney Disease

I cannot provide a recommendation regarding "Heraclene" use in CKD because this medication name does not appear in any of the provided evidence, medical literature, or standard drug references.

Critical Issue: Unidentified Medication

The term "Heraclene" does not correspond to any known generic or brand name medication in current pharmacological databases. This could represent:

  • A misspelling of an existing medication
  • A regional or non-standard drug name
  • A compounded or investigational agent
  • A misheard medication name

General Principles for Any Medication in CKD

While I cannot address "Heraclene" specifically, the following framework applies to all medications being considered for CKD patients:

Mandatory Safety Assessment 1, 2

  • Always consider GFR when dosing medications cleared by the kidneys 1
  • People with CKD may be more susceptible to nephrotoxic effects of medications - the benefit versus potential harm must always be weighed 1
  • Monitor eGFR, electrolytes, and therapeutic medication levels when indicated for drugs with narrow therapeutic windows or potential nephrotoxicity 1

Medication Review Requirements 1, 3

  • Perform thorough medication review periodically and at transitions of care to assess adherence, continued indication, and potential drug interactions 1
  • Review and limit over-the-counter medicines and dietary/herbal remedies that may be harmful 1
  • Nearly half of all medications are eliminated via the kidney, making dose adjustment critical 2

Risk Stratification by CKD Stage 1, 4

  • GFR ≥60 mL/min/1.73 m² (G1-G2): Most medications require standard dosing with routine monitoring
  • GFR 30-59 mL/min/1.73 m² (G3a-G3b): Many medications require dose reduction; increased monitoring frequency 1
  • GFR 15-29 mL/min/1.73 m² (G4): Significant dose adjustments needed; avoid certain nephrotoxic agents 1
  • GFR <15 mL/min/1.73 m² (G5): Severe restrictions apply; many medications contraindicated 1

Next Steps Required

To provide accurate guidance, please clarify:

  1. The correct spelling or generic name of the medication
  2. The therapeutic class (e.g., antibiotic, antihypertensive, analgesic)
  3. The patient's specific eGFR value
  4. The indication for use

Common medication names that sound similar and require CKD considerations include various antibiotics, cardiovascular agents, and analgesics - all of which have specific dosing guidelines in renal impairment 1, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Medication Safety Principles and Practice in CKD.

Clinical journal of the American Society of Nephrology : CJASN, 2018

Research

Prescribing and deprescribing in chronic kidney disease.

Australian journal of general practice, 2021

Research

Medication safety in chronic kidney disease.

Current opinion in nephrology and hypertension, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.